Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

DipHIV > BHIVA/BASHH/BIA adult HIV testing 2020 > Flashcards

BHIVA/BASHH/BIA adult HIV testing 2020 Flashcards

1
Q

What are the 3 key benefits of early initiation ART?

A

for patient - reduce morbidity and mortality
for partner - reduce risk of transmission
for public - reduce community HIV transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What proportion of people living with HIV remain undiagnosed?

A

7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What proportion of people living with HIV present with a late diagnosis?

A

43%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the problem with late diagnosis presentation of HIV?

A

Higher risk of morbidity and mortality both short and long term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Those who are HIV negative but at risk of HIV what 3 public health measures should be offered?

A

Condoms
Regular testing
Health promotion around safe sex/harm reduction
PrEP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the window period for 4th generation serological HIV testing?

A

45 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In 2018, what proportion of people were -
diagnosed with HIV,
on ART and
with a undetectable viral load?

A

93% DIAGNOSED
97% on ART
97% undetectable VL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which high risk group has had the most marked reduction in HIV new diagnoses?

A

MSM in London

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the most likely reasons for the reduction in incidence of HIV?

A

Increased testing
Repeat testing
Treatment as prevention (TasP)
PrEP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

At what prevalence of undiagnosed HIV is it cost effective to provide HIV screening?

A

0.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the undiagnosed prevalence in England?

A

0.016%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is it considered cost effective to provide HIV screening across England?

A

NO

Prevalence 0.016%, for cost effectiveness needs to be 0.1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

At what prevalence of undiagnosed HIV in pregnant women is it cost effective to provide HIV screening?

A

0.0075%

lower than the general population threshold due to larger costs associate with infant acquired HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the groups of people with increased risk of HIV? [hint: there are 10 and 1 bonus]

A 
SEXUAL RISK (5):
MSM
Female sex partners of MSM
Sex workers
Transwomen
Sex with a person from high diagnosed seroprevalence (>1%)
GEOGRAPHIC RISK (2):
Black Africans
Person from country with high diagnosed seroprevalence (>1%)
SOCIAL RISK (3):
PWID (past or current)
Prisoners (past or current)
Mother with HIV and no documented negative status

Bonus:
Transmen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What percentage is consider a high DIAGNOSED seroprevalance?

A

> 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In which FIVE healthcare settings should HIV testing be opt-testing as routine?

A 
SRH:
Sexual health services
Antenatal services
Termination of pregnancy services
BBV:
Addiction and substance misuse services
CONDITIONS WITH INCREASED RISK OF HIV:
Healthcare services for Hepatitis B or C, TB or Lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

There are 5 healthcare settings in which HIV testing should be routine. In what other clinical settings should patients be offered HIV testing?

A

Individuals starting:
Chemotherapy, immunosuppressive or immunomodulatory therapy
(as per NICE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the FIVE broad groups of people who should be offered HIV testing?

A

1) People in high risk groups
2) People attending certain healthcare settings
3) People with symptoms or signs of an HIV indicator condition
4) People accessing healthcare in areas of HIGH or EXTREMELY HIGH HIV seroprevalence (regardless of reason for attendance)
5) Sexual partners of those diagnosed with HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the the definition of high and extremely high prevalence of HIV?

A

HIGH - 2-5 per 1000

EXTREMELY high - >5 per 1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the estimated undiagnosed

prevalence of HIV in the UK for MSM?

A

0.681% (6-7 per 1000)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the estimated undiagnosed

prevalence of HIV in LONDON for MSM?

A

0.714%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the estimated undiagnosed

prevalence of HIV in the UK for Black African people?

A

0.165% (1-2 per 1000)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Is the estimated undiagnosed

prevalence of HIV in the UK higher for Black African MEN or WOMEN?

A

WOMEN

0.189% vs 0.136% for men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the estimated undiagnosed

prevalence of HIV in the UK for PWID?

A

0.089% (approx 1 per 1000)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the rate of uptake of HIV screening among women attending for antenatal care?

A

> 99%

very high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the percentage of positive HIV tests among women attending for antenatal care?

A

0.013%

ie > 0.0075% the cost effectiveness threshold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

From which countries are TWO studies used to support HIV testing in antenatal care?

A

Australia

USA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What did Public Health England use to model HIV prevalence distribution?

A

k-median cluster analysis

29
Q

What proportion of late HIV diagnoses were identified to occur in areas of high or extremely high prevalence of HIV?

A

TWO THIRDS (2/3)

30
Q

What is the aim of ‘geographical targeted testing’?

A

To REDUCE the number of individuals living with HIV who are UNAWARE
of their infection in geographical areas where UNDIAGNOSED PREVALENCE is high (>1 PER 1000)

31
Q

What is the benefit of ‘geographical targeted testing’?

A

Overcomes the need to target HIV testing to any specific population,
potentially PREVENTING further STIGMATISATION of these populations

32
Q

In what scenarios, should repeat HIV testing be done? [hint: there are 4]

A

1) If testing done within window period from last risk
2) ongoing high risk behaviour
3) Follow up testing for other STIs
4) PrEP monitoring

33
Q

Which THREE groups of people should have annual HIV testing at a MINIMUM?

A

PWID
Sex workers
MSM

34
Q

When should MSM be offered 3 monthly HIV testing?

A

1) condomless anal sex last 12 months
2) multiple or anonymous sexual partners
3) more than 10 sexual partners last 12 months
4) Drug use during sex last 6 months

35
Q

Drug use during sex is an independent risk factor for HIV transmission, HIV testing should be offered if this has occurred over what time period?

A

Drug use in last

SIX (6) MONTHS

36
Q

What strategies can be used to increase repeat HIV testing in groups? [hint: name 3]

A

1) Recall of people eligible for PrEP but declined
2) Text reminders
3) Home sampling kits

37
Q

There is limited data for repeat HIV testing in groups outwith MSM. What was the rate of HIV positivity in heterosexual population in LONDON?

A

1 out of 4584 (repeat testing within 12 months)

Retrospective review 31 469, heterosexual, diverse ethnicity. 4584 retested within 12 months - 1 HIV positive.

38
Q

At what prevalence of HIV is it cost effective to offer HIV testing annually for heterosexual populations?

A

0.8% prevalence

39
Q

During 3 month follow up of MSM diagnosed with bacterial STI in London, what proportion had a new STI and what proportion had HIV?

A

New STI - 29 out of 301
HIV - 5 out of 301
(301 MSM diagnosed with bacterial STI, 206 re-attended 6 months - 29 new STI and 5 HIV positive)

40
Q

What is the benefit for HIV testing using a mixed model (clinic-based+home-based) vs clinic only?

A

INCREASE in HIV positive INCIDENCE

4.2 vs 1.9 per year (Australia)

41
Q

What are THREE potential barriers to accessing health care based HIV testing?

A

1) inconvenience
2) confidentiality concerns
3) fear of stigma

42
Q

What THREE HIV testing systems offer alternatives to testing within sexual health services?

A

1) HIV self-testing (test + interpret at home)
2) self-sampling (collect sample + send to lab)
3) outreach community testing

43
Q

What is the term used to describe a self-sampling HIV test that shows a positive result?

A

REACTIVE

there is a small possibility of a false positive

44
Q

In Europe, what is the sensitivity and specificity of all approved blood-based self-test HIV testing kits?

A

> 99%

45
Q

In Europe, what is the assay used for all approved blood-based self-test HIV testing kits?

A

2nd or 3rd generation assay

mostly 3rd in UK

46
Q

If a persons self-test for HIV is reactive, what must be performed next?

A

A confirmatory laboratory test

there is a small possibility of a false positive

47
Q

HIV self-testing is highly acceptable, what benefits do patients cite?

A

1) ease
2) convenience
3) privacy
4) immediacy
5) anonymity
6) no need to visit healthcare centre

48
Q

What barriers are reported by patients to using HIV self-tests?

A

1) cost
2) fear of carrying out blood test
3) interpreting outcome
4) having a reactive result without support

49
Q

What is the potential positive impact of using oral fluid self-tests for HIV testing?

A

TWO fold increase in testing UPTAKE

50
Q

HIV test window period should be based on 99th percentile estimates, what is the window period for 4th generation laboratory tests?

A

FOURTY FIVE (45) days

51
Q

HIV test window period should be based on 99th percentile estimates, what is the window period for 3rd generation laboratory tests?

A

SIXTY (60) days

52
Q

HIV test window period should be based on 99th percentile estimates, what is the window period for point of care tests?

A

NINETY (90) days

53
Q

When should molecular assay for viral RNA or proviral DNA be used as part of the screening or confirmatory test?

A

1) Primary HIV infection

2) Indeterminate serology on PrEP

54
Q

Diagnosing breakthrough HIV infections on PrEP can be challenging. What THREE tests might be used?

A

1) ANTIGEN/ANTIBODY 4th generation
2) RNA and proviral DNA MOLECULAR ASSAY
3) WESTERN BLOT

55
Q

How should you manage/follow up atypical or non-confirmatory HIV tests on PrEP?

A

Stop PrEP

Repeat HIV test at 4 weeks and 8 weeks

56
Q

What THREE situations might blunt the HIV antibody response and therefore result in an atypical HIV serology?

A

1) PEP
2) PrEP
3) early ART initiation

57
Q

BARRIERS to HIV testing, STRUCTURAL/ORGANISTATIONAL level - what are they?

A

1) ACCESS to service
- geographical distance, opening times, length of waiting time, time for test result
2) testing ENVIRONMENT
3) service CAPACITY
- insufficient time, training gaps
4) COST

58
Q

BARRIERS to HIV testing, HEALTHCARE PROFESSIONAL level - what are they?

A

LACK of

1) KNOWLEDGE and SKILLS who to test
2) relevant COMMUNICATION skills
3) POCT skills

59
Q

BARRIERS to HIV testing, INDIVIDUAL level - what are they?

A

1) Lack of AWARENESS for need to test
2) FEAR of positive result or HIV illness
3) Lack of KNOWLEDGE of benefit of treatment

60
Q

What symptoms or signs should prompt HIV testing?

A 
Mononucleosis-like illness
Fever
Lymphadenopathy
UNEXPLAINED
- weight loss
- diarrhoea
- fever
- oral candidiasis
61
Q

What aspects to a routine blood panel that might be abnormal should prompt HIV testing?

A

leucocytopenia
thrombocytopenia
chronic renal impairment

62
Q

What VIRAL infections should prompt HIV testing?

A 
HZV
HSV
CMV
Hepatitis A, B, C
JC virus (PML)
63
Q

What NEOPLASIA should prompt HIV testing?

A 
Cervical dysplasia/cancer
Anal dysplasia/cancer
Malignant lymphoma
Primary lung cancer
Kaposi’s sarcoma
64
Q

What BACTERIAL infections should prompt HIV testing?

A 
Community acquired pneumonia 
TB
MAC
Salmonella septicaemia (recurrent)
STI
Invasive pneumococcal disease
65
Q

What PARASITIC infections should prompt HIV testing?

A

Cerebral toxoplasmosis
Cryptosporidiosis diarrhoea
Cystoisosporiasis (isosporiasis)
Visceral leishmaniasis

66
Q

What FUNGAL infections should prompt HIV testing?

A 
PCP
Candidiasis (oral, GI, respiratory, blood)
Crytococcus
Histoplasmosis
Coccidioidomycosis
Talaromycosis
67
Q

What DERMATOLOGICAL presentations should prompt HIV testing?

A

Seborrhoeic dermatitis
Psoriasis (severe or atypical)
Oral hairy leukoplakia

68
Q

What NEUROLOGICAL presentations should prompt HIV testing?

A

Mononeuritis
Peripheral neuropathy
Multiple sclerosis-like disease
Guillain-Barre syndrome

DipHIV (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions